These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34659937)
1. Fibroblast Growth Factor 21 and Its Association With Oxidative Stress and Lipid Profile in Type 2 Diabetes Mellitus. Aleem M; Maqsood H; Younus S; Zafar AF; Talpur AS; Shakeel H Cureus; 2021 Sep; 13(9):e17723. PubMed ID: 34659937 [TBL] [Abstract][Full Text] [Related]
2. [Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes]. Zamaklar M; Lalić K; Rajković N; Trifunović D; Dragasević M; Popović L; Drasković D; Laić N; Jotić A; Vasović O; Lukić L; Milicić T; Potpara T Vojnosanit Pregl; 2005; 62(7-8):529-36. PubMed ID: 16171015 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
4. [Correlations between lipid ratio/oxidative stress status in COPD patients and pulmonary hypertension as well as prognosis]. Li C; Yan L; Xu J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1168-1174. PubMed ID: 27932762 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia. Aleem M; Zainab A; Hameed A; Khan AB; Ali SZ; Younus S Cureus; 2022 Feb; 14(2):e22595. PubMed ID: 35371720 [TBL] [Abstract][Full Text] [Related]
6. An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients. Manohar SM; Vaikasuvu SR; Deepthi K; Sachan A; Narasimha SR J Res Med Sci; 2013 Feb; 18(2):89-93. PubMed ID: 23914207 [TBL] [Abstract][Full Text] [Related]
7. Malondialdehyde and Zinc May Relate to Severity of Microvascular Complications in Diabetes: A Preliminary Study on Older Adults with Type 2 Diabetes Mellitus in Northeast China. Sun M; Yan G; Sun S; Li X; Sun W; Wang Y Clin Interv Aging; 2024; 19():1141-1151. PubMed ID: 38948168 [TBL] [Abstract][Full Text] [Related]
8. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of antioxidant status in diabetic patients with and without insulin resistance. Ibrahim SL; Al-Dawah NKJ; Al-Barqaawi MA J Med Life; 2023 Sep; 16(9):1321-1326. PubMed ID: 38107710 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. Lin Z; Wu Z; Yin X; Liu Y; Yan X; Lin S; Xiao J; Wang X; Feng W; Li X PLoS One; 2010 Dec; 5(12):e15534. PubMed ID: 21206918 [TBL] [Abstract][Full Text] [Related]
11. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Hussain A; Ali I; Ijaz M; Rahim A Ther Adv Endocrinol Metab; 2017 Apr; 8(4):51-57. PubMed ID: 28507727 [TBL] [Abstract][Full Text] [Related]
12. Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus. Annadurai T; Vasanthakumar A; Geraldine P; Thomas PA Diabetes Res Clin Pract; 2014 Jul; 105(1):58-69. PubMed ID: 24842247 [TBL] [Abstract][Full Text] [Related]
13. Diabetic dyslipidemia. Kreisberg RA Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665 [TBL] [Abstract][Full Text] [Related]
14. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy. Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142 [TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
16. Correlation of Fasting Blood Sugar and Glycated Hemoglobin (HbA1c) With Thiamine Levels in Diabetic Patients. Khan MU; Mubeen M; Chohan HK; Jawed S; Jamal A; Qamar JA; Chohan MK; Siddiqui AA; Anwar A; Hashmi AA Cureus; 2023 Sep; 15(9):e46178. PubMed ID: 37905298 [TBL] [Abstract][Full Text] [Related]
17. Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men. Nour Eldin EE; Almarzouki A; Assiri AM; Elsheikh OM; Mohamed BE; Babakr AT Diabetol Metab Syndr; 2014; 6(1):94. PubMed ID: 25221629 [TBL] [Abstract][Full Text] [Related]
18. Comparison of lipid profile in type-2 obese diabetics and obese non-diabetic individuals. a hospital based study from Western Nepal. Yadav NK; Thanpari C; Shrewastwa MK; Mittal RK Kathmandu Univ Med J (KUMJ); 2012; 10(39):44-7. PubMed ID: 23434961 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of serum high-density lipoprotein and low-density lipoprotein levels and glycated hemoglobin levels and periodontal status in type 2 diabetic patients: A pilot project. Shetty S; Thoudam BD; Thokchom N; Khumukcham S; Sajjan A; Ponnan S J Oral Maxillofac Pathol; 2022; 26(3):421. PubMed ID: 36588826 [TBL] [Abstract][Full Text] [Related]
20. Association of trace metal elements with lipid profiles in type 2 diabetes mellitus patients: a cross sectional study. Wolide AD; Zawdie B; Alemayehu T; Tadesse S BMC Endocr Disord; 2017 Oct; 17(1):64. PubMed ID: 29029608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]